Case Report: Anlotinib Combined with PD-1 Inhibitor and Sequential GA Regimen or FOLFIRINOX Chemotherapy in Treatment of KRAS G12V Mutated Pancreatic Ductal Adenocarcinoma with Liver Metastasis: A Case and Literature Review
Frontiers in Immunology（2022）
关键词
Anlotinib,PD-1 inhibitor,chemotherapy,metastatic pancreatic ductal adenocarcinoma,KRAS,case report
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要